Trabectedin plus pegylated liposomal doxorubicin (PLD) versus PLD in recurrent ovarian cancer: overall survival analysis (Q84027945)
Jump to navigation
Jump to search
scientific article published on 26 April 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Trabectedin plus pegylated liposomal doxorubicin (PLD) versus PLD in recurrent ovarian cancer: overall survival analysis |
scientific article published on 26 April 2012 |
Statements
Trabectedin plus pegylated liposomal doxorubicin (PLD) versus PLD in recurrent ovarian cancer: overall survival analysis (English)
Thomas J Herzog
Stanley B Kaye
Carolyn N Krasner
Jan B Vermorken
Eric Pujade-Lauraine
Youn C Park
Trilok V Parekh
Andres M Poveda
26 April 2012